James Corbett - Jun 5, 2024 Form 4 Insider Report for AVITA Medical, Inc. (RCEL)

Role
CEO, Director
Signature
/s/ Donna Shiroma
Stock symbol
RCEL
Transactions as of
Jun 5, 2024
Transactions value $
$0
Form type
4
Date filed
6/6/2024, 07:02 PM
Previous filing
Dec 27, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction RCEL Stock Options (Right to Buy) Award $0 +350K $0.00 350K Jun 5, 2024 Common Stock 350K $12.64 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Pursuant to Mr. Corbett's Employment Agreement, he is eligible for annual equity grants. On January 3, 2024, the Board of Directors approved a grant of 350,000 options to acquire 350,000 shares of Common Stock of the Company to Mr. Corbett, with an effective grant date of January 3, 2024 and an exercise price equal to the closing price of a share of Common Stock on Nasdaq on January 3, 2024 of $12.64. The grant was subject to the approval of the Company's stockholders, which was obtained on June 5, 2024.
F2 These Stock Options vest in three equal annual installments beginning on the date 12 months following the grant date of January 3, 2024.